Preventive effect of polynucleotide on post-thyroidectomy scars: A randomized, double-blinded, controlled trial

Ji Hee Kim, Jong Ju Jeong, Young In Lee, Won Jai Lee, Chorok Lee, Woong Youn Chung, Kee Hyun Nam, JuHee Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Objective: Polynucleotide (PN) provides a structural scaffold to induce anti-inflammatory and enhanced wound healing properties, and this study aimed to assess the efficacy of PN administration in the prevention of post-operative scars after conventional open total thyroidectomy. Study Design Materials and Methods: Forty-two patients with thyroid carcinoma who underwent total thyroidectomy were randomly assigned to the study (PN administration) or control (normal saline) group. All patients underwent a single session of combined ablative and non-ablative fractional laser. The Vancouver Scar Scale (VSS), global photographic assessment, and objective scar were assessed using three-dimensional (3D) camera at baseline and at 2, 4, 8, and 16 weeks after surgery. Results: Patients who underwent PN injection demonstrated better surgical scar quality outcome. Participants in the PN administration group had lower VSS scores than the control group (2.09 ± 0.47 vs. 4.01 ± 0.55, respectively) and lower scar height (0.23 ± 0.03 vs. 0.29 ± 0.03, respectively), as measured using 3D imaging. Furthermore, in the PN injected group, the degree of erythema, and pigmentation of the scar were less prominent. No patient developed hypertrophic scar or keloids on the surgical site. No other adverse events, including post-inflammatory hyperpigmentation, scarring, or infection, were observed. Conclusion: Adjuvant administration of PN along with conventional fractional laser treatment led to more favorable effect in wound healing and post-operative scar prevention after thyroidectomy. Lasers Surg. Med. 50:755–762, 2018.

Original languageEnglish
Pages (from-to)755-762
Number of pages8
JournalLasers in Surgery and Medicine
Volume50
Issue number7
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Polynucleotides
Thyroidectomy
Cicatrix
Lasers
Wound Healing
Hypertrophic Cicatrix
Keloid
Hyperpigmentation
Pigmentation
Erythema
Thyroid Neoplasms
Anti-Inflammatory Agents
Control Groups
Injections

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

Kim, Ji Hee ; Jeong, Jong Ju ; Lee, Young In ; Lee, Won Jai ; Lee, Chorok ; Chung, Woong Youn ; Nam, Kee Hyun ; Lee, JuHee. / Preventive effect of polynucleotide on post-thyroidectomy scars : A randomized, double-blinded, controlled trial. In: Lasers in Surgery and Medicine. 2018 ; Vol. 50, No. 7. pp. 755-762.
@article{9d396863ad3d405e861258e5318c94e0,
title = "Preventive effect of polynucleotide on post-thyroidectomy scars: A randomized, double-blinded, controlled trial",
abstract = "Background and Objective: Polynucleotide (PN) provides a structural scaffold to induce anti-inflammatory and enhanced wound healing properties, and this study aimed to assess the efficacy of PN administration in the prevention of post-operative scars after conventional open total thyroidectomy. Study Design Materials and Methods: Forty-two patients with thyroid carcinoma who underwent total thyroidectomy were randomly assigned to the study (PN administration) or control (normal saline) group. All patients underwent a single session of combined ablative and non-ablative fractional laser. The Vancouver Scar Scale (VSS), global photographic assessment, and objective scar were assessed using three-dimensional (3D) camera at baseline and at 2, 4, 8, and 16 weeks after surgery. Results: Patients who underwent PN injection demonstrated better surgical scar quality outcome. Participants in the PN administration group had lower VSS scores than the control group (2.09 ± 0.47 vs. 4.01 ± 0.55, respectively) and lower scar height (0.23 ± 0.03 vs. 0.29 ± 0.03, respectively), as measured using 3D imaging. Furthermore, in the PN injected group, the degree of erythema, and pigmentation of the scar were less prominent. No patient developed hypertrophic scar or keloids on the surgical site. No other adverse events, including post-inflammatory hyperpigmentation, scarring, or infection, were observed. Conclusion: Adjuvant administration of PN along with conventional fractional laser treatment led to more favorable effect in wound healing and post-operative scar prevention after thyroidectomy. Lasers Surg. Med. 50:755–762, 2018.",
author = "Kim, {Ji Hee} and Jeong, {Jong Ju} and Lee, {Young In} and Lee, {Won Jai} and Chorok Lee and Chung, {Woong Youn} and Nam, {Kee Hyun} and JuHee Lee",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/lsm.22812",
language = "English",
volume = "50",
pages = "755--762",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Preventive effect of polynucleotide on post-thyroidectomy scars : A randomized, double-blinded, controlled trial. / Kim, Ji Hee; Jeong, Jong Ju; Lee, Young In; Lee, Won Jai; Lee, Chorok; Chung, Woong Youn; Nam, Kee Hyun; Lee, JuHee.

In: Lasers in Surgery and Medicine, Vol. 50, No. 7, 01.09.2018, p. 755-762.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preventive effect of polynucleotide on post-thyroidectomy scars

T2 - A randomized, double-blinded, controlled trial

AU - Kim, Ji Hee

AU - Jeong, Jong Ju

AU - Lee, Young In

AU - Lee, Won Jai

AU - Lee, Chorok

AU - Chung, Woong Youn

AU - Nam, Kee Hyun

AU - Lee, JuHee

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background and Objective: Polynucleotide (PN) provides a structural scaffold to induce anti-inflammatory and enhanced wound healing properties, and this study aimed to assess the efficacy of PN administration in the prevention of post-operative scars after conventional open total thyroidectomy. Study Design Materials and Methods: Forty-two patients with thyroid carcinoma who underwent total thyroidectomy were randomly assigned to the study (PN administration) or control (normal saline) group. All patients underwent a single session of combined ablative and non-ablative fractional laser. The Vancouver Scar Scale (VSS), global photographic assessment, and objective scar were assessed using three-dimensional (3D) camera at baseline and at 2, 4, 8, and 16 weeks after surgery. Results: Patients who underwent PN injection demonstrated better surgical scar quality outcome. Participants in the PN administration group had lower VSS scores than the control group (2.09 ± 0.47 vs. 4.01 ± 0.55, respectively) and lower scar height (0.23 ± 0.03 vs. 0.29 ± 0.03, respectively), as measured using 3D imaging. Furthermore, in the PN injected group, the degree of erythema, and pigmentation of the scar were less prominent. No patient developed hypertrophic scar or keloids on the surgical site. No other adverse events, including post-inflammatory hyperpigmentation, scarring, or infection, were observed. Conclusion: Adjuvant administration of PN along with conventional fractional laser treatment led to more favorable effect in wound healing and post-operative scar prevention after thyroidectomy. Lasers Surg. Med. 50:755–762, 2018.

AB - Background and Objective: Polynucleotide (PN) provides a structural scaffold to induce anti-inflammatory and enhanced wound healing properties, and this study aimed to assess the efficacy of PN administration in the prevention of post-operative scars after conventional open total thyroidectomy. Study Design Materials and Methods: Forty-two patients with thyroid carcinoma who underwent total thyroidectomy were randomly assigned to the study (PN administration) or control (normal saline) group. All patients underwent a single session of combined ablative and non-ablative fractional laser. The Vancouver Scar Scale (VSS), global photographic assessment, and objective scar were assessed using three-dimensional (3D) camera at baseline and at 2, 4, 8, and 16 weeks after surgery. Results: Patients who underwent PN injection demonstrated better surgical scar quality outcome. Participants in the PN administration group had lower VSS scores than the control group (2.09 ± 0.47 vs. 4.01 ± 0.55, respectively) and lower scar height (0.23 ± 0.03 vs. 0.29 ± 0.03, respectively), as measured using 3D imaging. Furthermore, in the PN injected group, the degree of erythema, and pigmentation of the scar were less prominent. No patient developed hypertrophic scar or keloids on the surgical site. No other adverse events, including post-inflammatory hyperpigmentation, scarring, or infection, were observed. Conclusion: Adjuvant administration of PN along with conventional fractional laser treatment led to more favorable effect in wound healing and post-operative scar prevention after thyroidectomy. Lasers Surg. Med. 50:755–762, 2018.

UR - http://www.scopus.com/inward/record.url?scp=85044382139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044382139&partnerID=8YFLogxK

U2 - 10.1002/lsm.22812

DO - 10.1002/lsm.22812

M3 - Article

AN - SCOPUS:85044382139

VL - 50

SP - 755

EP - 762

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 7

ER -